Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Read More @ https://events.marketsandmarkets.com/5th-annual-marketsandmarkets-real-world-evidence-and-life-science-analytics-conference/

DATES & VENUE
20 Oct - 21 Oct 2022, All Day
#_REVIEWS